Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · IEX Real-Time Price · USD

10.25

-0.56 (-5.18%)

At close: Jul 2, 2024, 4:00 PM

10.80

+0.55 (5.37%)

After-hours: Jul 2, 2024, 5:53 PM EDT

Phathom Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-201.59	-197.72	-143.88	-129.07	-255.13	Upgrade
Depreciation & Amortization	0.58	0.62	0.52	0.32	0.01	Upgrade
Share-Based Compensation	45.03	24.13	16.81	5.84	0.41	Upgrade
Other Operating Activities	18.41	26.44	-21.91	53.22	218.21	Upgrade
Operating Cash Flow	-137.58	-146.53	-148.46	-69.69	-36.51	Upgrade
Capital Expenditures	-1.63	-1.04	-0.33	-1.04	-0.13	Upgrade
Other Investing Activities	-	-	-	-	-25.12	Upgrade
Investing Cash Flow	-1.63	-1.04	-0.33	-1.04	-25.25	Upgrade
Share Issuance / Repurchase	155.59	24.6	1.94	89.46	191.47	Upgrade
Debt Issued / Paid	211.99	95.45	42.76	25	113.17	Upgrade
Financing Cash Flow	367.58	120.04	44.71	114.46	304.65	Upgrade
Net Cash Flow	228.37	-27.53	-104.08	43.73	242.89	Upgrade
Free Cash Flow	-139.21	-147.57	-148.79	-70.73	-36.64	Upgrade
Free Cash Flow Margin	-20412.61%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-2.71	-3.77	-4.02	-2.13	-3.22	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).